Insider Trading Alert - CBK, VRNS And CNBKA Traded By Insiders

Friday, Dec. 18, 2015, 77 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $24.26 to $4,955,373.00.

Highlighted Stocks Traded by Insiders:

Christopher & Banks (CBK) - FREE Research Report

Komarek Luke, who is SVP, General Counsel at Christopher & Banks, bought 4,500 shares at $1.14 on Dec. 18, 2015. Following this transaction, the SVP, General Counsel owned 60,502 shares meaning that the stake was boosted by 8.04% with the 4,500-share transaction.

Sharpe William F. III, who is Director at Christopher & Banks, bought 5,000 shares at $1.10 on Dec. 18, 2015. Following this transaction, the Director owned 91,030 shares meaning that the stake was boosted by 5.81% with the 5,000-share transaction.

The shares most recently traded at $1.28, up $0.18, or 14.37% since the insider transaction. Historical insider transactions for Christopher & Banks go as follows:

  • 4-Week # shares bought: 195,090
  • 4-Week # shares sold: 20,500
  • 12-Week # shares bought: 195,090
  • 12-Week # shares sold: 20,500
  • 24-Week # shares bought: 195,090
  • 24-Week # shares sold: 20,500

The average volume for Christopher & Banks has been 640,200 shares per day over the past 30 days. Christopher & Banks has a market cap of $44.7 million and is part of the services sector and retail industry. Shares are down 77.93% year-to-date as of the close of trading on Friday.

Christopher & Banks Corporation, through its subsidiaries, operates as a retailer of women's apparel and accessories in the United States. The company designs, sources, and sells women's apparel and accessories to customers ranging in age from 45 to 60. The company has a P/E ratio of 1.6. Currently, there is 1 analyst who rates Christopher & Banks a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CBK - FREE

TheStreet Quant Ratings rates Christopher & Banks as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, weak operating cash flow and a generally disappointing performance in the stock itself. Get the full Christopher & Banks Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Citi Trends Tries to Fend Off Directors Linked With Failed Retailers

Insider Trading Alert - SRC, SAFM And CBK Traded By Insiders

Insider Trading Alert - CBK, CBG And HUN Traded By Insiders

Christopher & Banks (CBK) Stock Plunging on Preliminary Sales Results